Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
66 participants
INTERVENTIONAL
2010-12-31
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate a New Silicone Hydrogel Contact Lens
NCT01309893
Evaluation of the Feasibility a New Silicone Hydrogel Contact Lens
NCT01309906
Product Feasibility of a New Silicone Hydrogel Contact Lens
NCT01309100
Feasibility of a New Silicone Hydrogel Lens
NCT01131130
A Study to Evaluate the Product Feasibility of Two New Silicone Hydrogel Contact Lenses
NCT01583868
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Air Optix Aqua
Ciba Vision daily wear contact lens
Air Optix Aqua
Air Optix Aqua contact lens worn on a daily wear basis
Test Lens
Investigational silicone hydrogel contact lens
Test lens
Investigational silicone hydrogel contact lens worn on a daily wear basis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Test lens
Investigational silicone hydrogel contact lens worn on a daily wear basis
Air Optix Aqua
Air Optix Aqua contact lens worn on a daily wear basis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.
Exclusion Criteria
* Any systemic disease affecting ocular health.
* Using any systemic or topical medications that will affect ocular physiology or lens performance.
* An active ocular disease, any corneal infiltrative response or are using any ocular medications.
* Any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
* Allergic to any component in the study care products.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bausch & Lomb Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Beverly Barna
Role: STUDY_DIRECTOR
Bausch & Lomb Incorporated
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bausch & Lomb, Incorporated
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
686E
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.